Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma by Bao, Riyue, Spranger, Stefani, Hernandez, Kyle, Zha, Yuanyuan, Pytel, Peter, Luke, Jason J, Gajewski, Thomas F, Volchenboum, Samuel L, Cohn, Susan L, Desai, Ami V

Get full text

Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins by Fessenden, Tim B, Stopfer, Lauren E, Chatterjee, Fiona, Zulueta, Julian, Mesfin, Josh, Cordero Dumit, Therese, Reijers, Irene, Hoefsmit, Esmee P, Blank, Christian, White, Forest, Spranger, Stefani

Get full text

A team effort: natural killer cells on the first leg of the tumor immunity relay race by Fessenden, Timothy B, Duong, Ellen, Spranger-Zimmermann, Stefani

Get full text
Get full text

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19 by Spranger, Stefani

Get full text

Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy) by Spranger-Zimmermann, Stefani

Get full text

Impact of anatomic site on antigen-presenting cells in cancer by Zagorulya, Maria, Duong, Ellen, Spranger, Stefani

Get full text

Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma by Trujillo, Jonathan A, Luke, Jason J, Zha, Yuanyuan, Segal, Jeremy P, Ritterhouse, Lauren L, Spranger-Zimmermann, Stefani, Matijevich, Karen, Gajewski, Thomas F

Get full text

A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models by Tay, Apple Hui Min, Prieto-Díaz, Rubén, Neo, Shiyong, Tong, Le, Chen, Xinsong, Carannante, Valentina, Önfelt, Björn, Hartman, Johan, Haglund, Felix, Majellaro, Maria, Azuaje, Jhonny, Garcia-Mera, Xerardo, Brea, Jose M., Loza, Maria I., Jespers, Willem, Gutierrez-de-Teran, Hugo, Sotelo, Eddy, Lundqvist, Andreas

Get full text

Harnessing novel strategies and cell types to overcome immune tolerance during adoptive cell therapy in cancer by Neo, Shi Yong, Xu, Shengli, Chong, Joni, Lam, Kong-Peng, Wu, Jing

Get full text

PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment by Collins, Natalie B, Al Abosy, Rose, Miller, Brian C, Bi, Kevin, Zhao, Qihong, Quigley, Michael, Ishizuka, Jeffrey J, Yates, Kathleen B, Pope, Hans W, Manguso, Robert T, Shrestha, Yashaswi, Wadsworth, Marc, Hughes, Travis, Shalek, Alex K, Boehm, Jesse S, Hahn, William C, Doench, John G, Haining, W Nicholas

Get full text

Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition by Naik, Girish, Waikar, Sushrut S., Johnson, Alistair Edward William, Buchbinder, Elizabeth I., Haq, Rizwan, Hodi, F. Stephen, Schoenfeld, Jonathan D., Ott, Patrick A.

Get full text

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer by Ricciuti, Biagio, Kravets, Sasha, Dahlberg, Suzanne E., Umeton, Renato, Albayrak, Adem, Subegdjo, Safiya J., Johnson, Bruce E., Nishino, Mizuki, Sholl, Lynette M., Awad, Mark M.

Get full text